Worldwide sales of drugs for schizophrenia, 1993–2007.

[Guest guest]

..

http://www.nature.com/nrd/journal/v7/n6/fig_tab/nrd2571_F1.html

Worldwide sales of drugs for schizophrenia, 1993–2007.

From the following article:

Schizophrenia therapy: beyond atypical antipsychotics

M. Snyder & R.

Nature Reviews Drug Discovery 7, 471-472 (June 2008)

doi:10.1038/nrd2571

Back to article |

Back to figures and tables |

Next figure

The schizophrenia drug market has grown from less than $1 billion annually in 1993 to more than $10 billion. This rapid growth has followed the introduction of Risperdal in 1993, followed by Zyprexa, Seroquel, Geodon (ziprasidone; Pfizer) and Abilify (aripiprazole; Bristol–Myers Squibb). Annual prescriptions have increased from 20 million to more than 40 million in this time. Source: IMS.